nelarabine
novartis
['elara', 'leukemia', 'nelarabine']
congress| #ash22 yoshihiro hatta from nihon university school of med presents phase ii study of risk-stratified therapy with nelarabine and intensified administration of l-asp in ya pts with nd t-all: jplsg all-t11/jalsg t-all-211 trial. excellent os and efs rates were reported 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm